Für statistische Zwecke und um bestmögliche Funktionalität zu bieten, speichert diese Website Cookies auf Ihrem Gerät. Das Speichern von Cookies kann in den Browser-Einstellungen deaktiviert werden. Wenn Sie die Website weiter nutzen, stimmen Sie der Verwendung von Cookies zu.
Cookie akzeptieren![Reichle, Albrecht (Hrsg.). Evolution-adjusted Tumor Pathophysiology: - The Novel Language of Tumor Biology. Springer Netherlands, 2013.](https://eichendorff21.de/cdata/_vkQ3LbXgeqzr6rmfpFNMaaghEU=/300x0/9789400768659.png)
Evolution-adjusted Tumor Pathophysiology:
- Springer Netherlands
- 2013
- Gebunden
- 464 Seiten
- ISBN 9789400768659
Combined modularized therapies for metastatic cancer are pointing to central problems of communication among ¿systems participators¿. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of rationalizations constituting the tumor's normativity (inflammation, immune response etc.) represents the non-genomic counterpart of the tumor genome and should be additionally assessed during tumor staging. Evolution-adjusted tumor pathophysiology allows implementing applied systems biology, a novel clinical and pharmaceutical technology for bioengineering tumor response and personalizing tumor therapy. Combined modularized therapy, evolution-adjusted tumor pathophysiology, and ¿universal¿ biomarkers concertedly address genetically based
Mehr
Weniger
zzgl. Versand
in Kürze